1,402,022 filings since 2004 · latest accepted Nov 4, 2026, 7:13 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Aug 14, 2023 accepted 3:56 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.01Acquisition / disposition | DocumentSEC ↗ |
Oct 5, 2021 accepted 12:10 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreementAcquisition / disposition |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Apr 1, 2021 accepted 12:10 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale5.02Officer / director change7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Dec 22, 2017 accepted 1:31 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.01Acquisition / disposition3.02Unregistered equity sale3.03Holder rights modified4.01Auditor change5.01Change in control5.02Officer / director change5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |
May 19, 2014 accepted 9:30 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale5.02Officer / director change8.01Other events | DocumentSEC ↗ |